Target：Cripto-3

Gene Name：TDGF1P3

Protein Name：Putative teratocarcinoma-derived growth factor 3

Human Swiss Prot No：P51864

Immunogen：The antiserum was produced against synthesized peptide derived from the Internal region of human TDGF1P3. AA range:1-50

Specificity：Cripto-3 Polyclonal Antibody detects endogenous levels of Cripto-3 protein.

Formulation：Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Source：Polyclonal, Rabbit,IgG

Dilution：WB 1:500 - 1:2000. ELISA: 1:10000. Not yet tested in other applications.

Purification：The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration：1 mg/ml

Storage Stability：-15°C to -25°C/1 year(Do not lower than -25°C)

Other Name：TDGF1P3;CRIPTO3;TDGF2;TDGF3;Putative teratocarcinoma-derived growth factor 3;Cripto-3 growth factor;Epidermal growth factor-like cripto protein CR3;Teratocarcinoma-derived growth factor 1 pseudogene 3

Observed Band(KD)：21kD

Background： The TDGF3 locus has characteristics of a retrotransposon, including lack of introns and a poly(A) sequence. [provided by RefSeq, Jul 2008],

Function：function:Could play a role in the determination of the epiblastic cells that subsequently give rise to the mesoderm.,similarity:Contains 1 EGF-like domain.,tissue specificity:Preferentially expressed in gastric and colorectal carcinomas than in their normal counterparts.,

Subcellular Location：Cell membrane .

Expression：Expressed weakly in lung, colon and breast. Expressed also strongly in primary cancer tissues; lung and colon cancers.